IL140070A0 - Benzamide derivatives and pharmaceutical compositions containing the same - Google Patents

Benzamide derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL140070A0
IL140070A0 IL14007099A IL14007099A IL140070A0 IL 140070 A0 IL140070 A0 IL 140070A0 IL 14007099 A IL14007099 A IL 14007099A IL 14007099 A IL14007099 A IL 14007099A IL 140070 A0 IL140070 A0 IL 140070A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
benzamide derivatives
benzamide
Prior art date
Application number
IL14007099A
Other versions
IL140070A (en
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of IL140070A0 publication Critical patent/IL140070A0/en
Publication of IL140070A publication Critical patent/IL140070A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Abstract

Compounds of the formula Iin which R1, R2, R3, R4, R5, m and n have the meanings cited in the description, are novel effective PDE-inhibitors.
IL14007099A 1998-06-10 1999-05-27 Benzamide derivatives and pharmaceutical compositions containing the same IL140070A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98110710 1998-06-10
PCT/EP1999/003669 WO1999064414A1 (en) 1998-06-10 1999-05-27 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors

Publications (2)

Publication Number Publication Date
IL140070A0 true IL140070A0 (en) 2002-02-10
IL140070A IL140070A (en) 2004-06-20

Family

ID=8232103

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14007099A IL140070A (en) 1998-06-10 1999-05-27 Benzamide derivatives and pharmaceutical compositions containing the same

Country Status (14)

Country Link
US (1) US6303789B1 (en)
EP (1) EP1086096B1 (en)
JP (1) JP2002517495A (en)
AT (1) ATE245642T1 (en)
AU (1) AU757198B2 (en)
CA (1) CA2334979A1 (en)
DE (1) DE59906365D1 (en)
DK (1) DK1086096T3 (en)
ES (1) ES2205833T3 (en)
IL (1) IL140070A (en)
PT (1) PT1086096E (en)
SI (1) SI1086096T1 (en)
WO (1) WO1999064414A1 (en)
ZA (1) ZA200007210B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953774B2 (en) * 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation
KR20040075004A (en) * 2001-12-14 2004-08-26 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. Method of inducing ovulation using non-polypeptide camp level modulator
WO2006117653A1 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Azole-based phosphodiesterase inhibitors
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US7998971B2 (en) 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
AR066016A1 (en) * 2007-04-11 2009-07-15 Alcon Res Ltd USE OF AN ALFA TNF INHIBITOR TOGETHER WITH AN ANTIHISTAMINE TO TREAT ALLERGIC RHINITIS AND ALLERGIC CONJUNCTIVITIS
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
JP5721722B2 (en) * 2009-10-01 2015-05-20 アルコン リサーチ， リミテッド Olopatadine composition and use thereof
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use
SG11202106517WA (en) 2018-12-28 2021-07-29 Regeneron Pharma Treatment of respiratory disorders with arachidonate15-lipoxygenase (alox15) inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3634861B2 (en) 1992-06-15 2005-03-30 セルテック リミテッド Trisubstituted phenyl derivatives as selective phosphodiesterase IV inhibitors
HUT72656A (en) 1992-07-28 1996-05-28 Rhone Poulenc Rorer Ltd Inhibitors of c-amp phosphodiesterase and tnf, their preparation pharmaceuticals contg. them and their use
GB9401460D0 (en) * 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
AU702346B2 (en) 1994-07-22 1999-02-18 Altana Pharma Ag Dihydrobenzofuranes
DE69620458T2 (en) 1995-12-05 2002-10-02 Darwin Discovery Ltd BENZOFURANE CARBOXAMIDES AND SULPHONAMIDES
JP4309475B2 (en) 1996-08-19 2009-08-05 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング New benzofuran-4-carboxamide

Also Published As

Publication number Publication date
AU4370099A (en) 1999-12-30
EP1086096B1 (en) 2003-07-23
DE59906365D1 (en) 2003-08-28
ATE245642T1 (en) 2003-08-15
US6303789B1 (en) 2001-10-16
SI1086096T1 (en) 2003-12-31
ES2205833T3 (en) 2004-05-01
PT1086096E (en) 2003-12-31
IL140070A (en) 2004-06-20
AU757198B2 (en) 2003-02-06
JP2002517495A (en) 2002-06-18
ZA200007210B (en) 2002-03-06
WO1999064414A1 (en) 1999-12-16
CA2334979A1 (en) 1999-12-16
EP1086096A1 (en) 2001-03-28
DK1086096T3 (en) 2003-11-10

Similar Documents

Publication Publication Date Title
MXPA03008754A (en) Pyridine derivatives.
MX9700557A (en) Dihydrobenzofuranes.
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
BG103485A (en) Ketobanzamides as calpain inhibitors
BG103413A (en) Derivatives of sulphinic acid, their production and application
HK1040721A1 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
MY116845A (en) New 19-nor-pregnene derivatives
CA2276455A1 (en) Phthalazinones
IL135536A0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
PL366198A1 (en) Novel compounds
TR199901282T2 (en) New heterocyclically substituted benzamides.
ES2136037A1 (en) Sulfamide-metalloprotease inhibitors
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
MY133969A (en) Indoloquinazolinones
IL136359A (en) Dihydrobenzofuran substituted phthalazin-1-one derivatives and pharmaceutical compositions containing the same
MY136297A (en) Piperazine derivatives having sst1 antagonistic activity
BG105710A (en) 5ht1 antagonists for antidepressant therapy
SI1377574T1 (en)
SE9904128D0 (en) Novel compounds
TR200001122T2 (en) Biphenyl derivatives as pharmaceuticals.
DE59803066D1 (en) SUBSTITUTED BENZYLOXYIMINO COMPOUNDS
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
IL159493A0 (en) Pharmaceutical formulation containing an ltb4 antagonist

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees